Article    Table of Contents                    Full Text of this article    PDF of this article (PDFs free after 6 months)    Figures/Tables List  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search    Get Permissions  Google Scholar    Search for Related Content  Social Bookmarking

What's this?

PubMed

Articles in PubMed by Author:    Albelda, S. M.    Zuckerman, J. B.    Related Articles in PubMed    PubMed Citation    PubMed

UPDATE

Gene Therapy for Lung Disease: Hype or Hope?

Steven M. Albelda, MD; Rainer Wiewrodt, MD; and Jonathan B. Zuckerman, MD

18 April 2000 | Volume 132 Issue 8 | Pages 649-660

Gene therapy, the treatment of any disorder or pathophysiologic state on the basis of the transfer of genetic information, was a high-priority goal in the 1990s. The lung is a major target of gene therapy for genetic disorders, such as cystic fibrosis and ₁-antitrypsin deficiency, and for other diseases, including lung cancer, malignant mesothelioma, pulmonary inflammation, surfactant deficiency, and pulmonary hypertension. This paper examines general concepts in gene therapy, summarizes the results of published clinical trials, and highlights areas of research aimed at overcoming challenges in the field. Although progress has been slower than anticipated, gene transfer has been safely achieved in patients with lung diseases. Recent advancements in understanding of the molecular basis of lung disease and the development of improved vector systems make it likely that gene therapy will be an important tool for the 21st-century clinician.

Author and Article Information

From University of Pennsylvania Medical Center, Philadelphia, Pennsylvania.

For definitions of terms, see Glossary at end of text.

Acknowledgments: The authors thank Kate Darwin and Linda Kalb for assistance in preparing the manuscript.

Grant Support: This work was supported by grant PO1 66726 from the National Cancer Institute, National Institutes of Health; the Benjamin Shein Foundation for Humanity; and the Lunenfield Foundation (Dr. Albelda). Dr. Wiewrodt is a postdoctoral fellow of Mildred Scheel Stiftung für Krebsforschung der Deutschen Krebshilfe e.V. (grant D/98/02288).

Requests for Single Reprints: Steven M. Albelda, MD, 856 BRBII/III, 421 Curie Boulevard, Philadelphia, PA 19104; e-mail, albelda{at}mail.med.upenn.edu.

Requests To Purchase Bulk Reprints (minimum, 100 copies): the Reprints Coordinator; phone, 215-351-2657; e-mail, reprints{at}mail.acponline.org.

Current Author Addresses: Dr. Albelda: 856 BRBII/III, 421 Curie Boulevard, Philadelphia, PA 19104.

Dr. Wiewrodt: 835 BRBII/III, 421 Curie Boulevard, Philadelphia, PA 19104.

Dr. Zuckerman: Pulmonary and Critical Care, Maine Medical Center, 22 Bramhall Street, Portland, ME 04102.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

This article has been cited by other articles:

				D. R. Koehler, U. Sajjan, Y.-H. Chow, B. Martin, G. Kent, A. K. Tanswell, C. McKerlie, J. F. Forstner, and J. Hu Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia PNAS, December 23, 2003; 100(26): 15364 - 15369. [Abstract] [Full Text] [PDF]

				H.-Y. Lee, Y.-A. Suh, J. I. Lee, K. A. Hassan, L. Mao, T. Force, B. E. Gilbert, T. Jacks, and J. M. Kurie Inhibition of Oncogenic K-ras Signaling by Aerosolized Gene Delivery in a Mouse Model of Human Lung Cancer Clin. Cancer Res., September 1, 2002; 8(9): 2970 - 2975. [Abstract] [Full Text] [PDF]

				M. I. Ebright, J. S. Zager, S. Malhotra, K. A. Delman, T. L. Weigel, V. W. Rusch, and Y. Fong Replication-competent herpes virus NV1020 as direct treatment of pleural cancer in a rat model J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 123 - 129. [Abstract] [Full Text] [PDF]

				C. J. Piyathilake, A. R. Frost, U. Manne, H. Weiss, W. C. Bell, D. C. Heimburger, and W. E. Grizzle Differential Expression of Growth Factors in Squamous Cell Carcinoma and Precancerous Lesions of the Lung Clin. Cancer Res., March 1, 2002; 8(3): 734 - 744. [Abstract] [Full Text] [PDF]

				Z. Borok, J. E. Harboe-Schmidt, S. L. Brody, Y. You, B. Zhou, X. Li, P. M. Cannon, K.-J. Kim, E. D. Crandall, and N. Kasahara Vesicular Stomatitis Virus G-Pseudotyped Lentivirus Vectors Mediate Efficient Apical Transduction of Polarized Quiescent Primary Alveolar Epithelial Cells J. Virol., December 1, 2001; 75(23): 11747 - 11754. [Abstract] [Full Text]

				D. A. Coil, J. H. Strickler, S. K. Rai, and A. D. Miller Jaagsiekte Sheep Retrovirus Env Protein Stabilizes Retrovirus Vectors against Inactivation by Lung Surfactant, Centrifugation, and Freeze-Thaw Cycling J. Virol., September 15, 2001; 75(18): 8864 - 8867. [Abstract] [Full Text] [PDF]

				M. Wu, S. Hussain, Y.-H. He, R. Pasula, P. A. Smith, and W. J. Martin II Genetically engineered macrophages expressing IFN-gamma restore alveolar immune function in scid mice PNAS, December 4, 2001; 98(25): 14589 - 14594. [Abstract] [Full Text] [PDF]